Discussing Safety and Value Solutions at ICPE

Visit UBC at ICPE Booth #12

Discussing Safety and Value Solutions at ICPE

The 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) will bring healthcare professionals together August 23 – 26 in Boston. This meeting is a great chance to discuss the trends in the industry with an eye on patient safety.

We’ve seen tighter regulations and cost containment measures driving the demand for post-marketing research for many of our clients. At the conference, our Value Demonstration scientists will explain some of their recent late stage research during the poster presentations:

Drug Utilization Study (DUS) Methodology: Applications and Challenges
Monday, August 24 – Noon to 1:30 p.m. – Poster #217
• Dara Stein, MSc, Senior Research Scientist
• Kristy Hanson, Scientific Consultant

Long-acting Bronchodilators and Risk of Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease: A Focused Critical Review
Wednesday, August 26 – 8 a.m. to 1:45 p.m. – Poster #32
• Sunning Tao, Research Scientist

Our tailored real-world evidence generation solutions can help demonstrate the value of pharmaceutical products to regulatory agencies, payers and pharmacists, speeding approval and commercialization efforts.

UBC’s Database Analytics Automation team will also be on-hand to demo our suite of software that leverages real-world healthcare data to provide rapid, reliable insight into the safety and utilization of marketed medications. Click here to learn more and check out a video overview of the software solutions.

Stop by exhibit #12 to learn more, request a demo of the DAA software, and register to win a pair of Bose noise-canceling headphones.